MedTrace Logo

Colonization of Skin by M. Luteus Q24 Probiotic

NCT06137209 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face from a serum format in healthy adults.

Conditions

  • Microbial Colonization

Interventions

OTHER

Active Comparator: Study Group A: Blis Q24 Serum at higher dose

Active Comparator: Study Group A: Blis Q24 Serum at 1e7 cfu/ dose (Active)

OTHER

Active Comparator: Study Group B: Blis Q24 Serum at lower dose

Active Comparator: Study Group B: Blis Q24 Serum at 1e6 cfu/ dose (Active)

Sponsors & Collaborators

  • BLIS Technologies Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2023-11-22
Completion
2024-03-15

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06137209 on ClinicalTrials.gov